Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells
Neuroimmunomodulation · 2021 · 28 (3) · 99-107
DOI: 10.1159/000515594 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuroimmunomodulation, online erschienen am 05.05.2021. Verfasst von Moisés E Bauer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunobiology, School of Health and Life Sciences, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Bipolar Disorder, Major Depressive Disorder. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
Mood disorders are associated with chronic low-grade systemic (sterile) inflammation, with increased plasma levels of pro-inflammatory mediators targeting all tissues including the brain. Importantly, pro-inflammatory cytokines (ex., tumor-necrosis factor alpha [TNF-α], interleukin [IL]-6) regulate mood behavior and cognition by influencing neurotransmitter levels, activating stress-responsive endocrine axes, among other effects. However, the mechanisms underlying this enhanced inflammation are not well understood. There is increasing evidence indicating that impaired immunoregulatory mechanisms may play a role in this context. Patients with mood disorders (major depression [MDD] and bipolar disorder [BD]) have reduced numbers of major regulatory cells of both innate (natural killer regulatory cells and myeloid-derived suppressor cells [MDSCs]) and adaptive immune responses (CD4+CD25+FoxP3+, B regulatory cells). Dysfunctional regulatory immune cells might contribute to systemic and neuroinflammation observed in mood disorders via different mechanisms, such as: (i) failure to develop adequate stress-related responses, (ii) indirectly through microglial activation, (iii) lack of trophic support and pro-cognitive functions of T cells in the brain, and (iv) dysbiosis. In conclusion, maladaptive immunoregulatory mechanisms seem to be involved with both onset and progression of mood disorders. A deeper understanding of these mechanisms may lead to the development of new therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunobiology, School of Health and Life Sciences, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.
- National Institute of Science and Technology - Neuroimmunomodulation (INCT-NIM), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brasília, Brazil.
- Institute of Education and Research, Santa Casa BH, Belo Horizonte, Brazil.
- Neuropsychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, Texas, USA.
Zitieren
APA
Bauer, M. E., & Teixeira, A. L. (2021). Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells. Neuroimmunomodulation, 28(3), 99-107. https://doi.org/10.1159/000515594
Vancouver
Bauer ME, Teixeira AL. Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells. Neuroimmunomodulation. 2021;28(3):99-107. doi:10.1159/000515594
BibTeX
@article{Bauer2021,
author = {Bauer, Moisés E and Teixeira, Antônio L},
title = {Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells},
journal = {Neuroimmunomodulation},
year = {2021},
volume = {28},
number = {3},
pages = {99--107},
doi = {10.1159/000515594}
}
EUVIMED